WordNet

the 1st letter of the Roman alphabet (同)a
the blood group whose red cells carry the A antigen (同)type_A, group A
the 8th letter of the Roman alphabet (同)h
any substance (as a toxin or enzyme) that stimulates an immune response in the body (especially the production of antibodies)

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein.

Jochems C, Tucker JA, Vergati M, Boyerinas B, Gulley JL, Schlom J, Tsang KY.SourceLaboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B09, MSC 1750, Bethesda, MD, 20892, USA.
Cancer immunology, immunotherapy : CII.Cancer Immunol Immunother.2013 Nov 15. [Epub ahead of print]
The MUC1 tumor-associated antigen is overexpressed in the majority of human carcinomas and several hematologic malignancies. Much attention has been paid to the hypoglycosylated variable number of tandem repeats (VNTR) region of the N-terminus of MUC1 as a vaccine target, and recombinant viral vecto
PMID 24233342

In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.

Pashov AD, Calvez T, Gilardin L, Maillère B, Repessé Y, Oldenburg J, Pavlova A, Kaveri SV, Lacroix-Desmazes S.SourceCentre de recherche des Cordeliers, INSERM, UMR S 872, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie-Paris6, UMR S 872, Paris, France; Centre de Recherche des Cordeliers, Université Paris Descartes, UMR S 872, Paris, France; Department of Immunology, Institute of Microbiology, BAS, Sofia, Bulgaria.
Haemophilia : the official journal of the World Federation of Hemophilia.Haemophilia.2013 Oct 14. doi: 10.1111/hae.12276. [Epub ahead of print]
Forty per cent of haemophilia A (HA) patients have missense mutations in the F8 gene. Yet, all patients with identical mutations are not at the same risk of developing factor VIII (FVIII) inhibitors. In severe HA patients, human leucocyte antigen (HLA) haplotype was identified as a risk factor for o
PMID 24118514

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients.

Wilgenhof S, Van Nuffel AM, Benteyn D, Corthals J, Aerts C, Heirman C, Van Riet I, Bonehill A, Thielemans K, Neyns B.SourceDepartments of Medical Oncology.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.Ann Oncol.2013 Oct;24(10):2686-93. doi: 10.1093/annonc/mdt245. Epub 2013 Jul 31.
BACKGROUND: Autologous monocyte-derived dendritic cells (DCs) electroporated with synthetic messenger RNA (mRNA) encoding a CD40 ligand, a constitutively active Toll-like receptor 4 and CD70, together with mRNA encoding fusion proteins of a human leukocyte antigen (HLA)-class II targeting signal (DC
PMID 23904461

今村展隆 [他],徳毛健治,小金丸茂喜,小熊信夫,岡田浩佑,蔵本淳
臨床血液 22(6), 885-890, 1981
… Repeated cytapheresis was carried out with the Haemonetics HM 30 Blood Cell Processor in a case of adult T-cell leukemia (ATL).A rapid clinical course, skin lesion, hepatosplenomegaly, lymph node enlargement and the presence of leukemic cells with indented nuclei possessing T-cell surface antigen of the peripheral T-cell type led to the diagnosis of ATL. …
NAID 130004917935